Cited by 1,547Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.

High-Density Lipoprotein — The Clinical Implications of Recent Studies

Desforges, Jane F., Gordon, David J., Rifkind, Basil M.·1989·New England Journal of Medicine

DOI 10.1056/nejm198911093211907

Open this paper in CoChat — free account

Abstract

DESPITE early observations suggesting an inverse relation between serum levels of high-density lipoprotein (HDL) cholesterol and coronary disease,1 2 3 the possible protective role of HDL in atherogenesis received little attention until its "rediscovery" by Miller and Miller4 in 1975 and the publication of confirmatory results from the Honolulu,5 Framingham,6 and Tromsø7 heart studies in 1976 and 1977. In the ensuing decade, research into the biochemistry, metabolism, epidemiology, and genetics of HDL has expanded rapidly, but many questions remain unanswered. The recent publication of the results of the Helsinki Heart Study8 , 9 — in which simultaneous 11 percent increases in HDL and reductions . . .

Integrity signals

Registry

Crossref · 10.1056/nejm198911093211907

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Self-citation
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,458
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts
Blankenhorn, D. H. (1987) · JAMA · doi:10.1001/jama.1987.03390230069027 · Cited by 1,654
Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.
Mattson, F. H., & Grundy, S. M. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34389-3 · Cited by 1,354

Show all 50 references

Research works printed but not linked: 10

Gofman, 1954, Plasma, 2, 413
Hulley, 1977, JAMA, 238, 2269, 10.1001/jama.1977.03280220037017 · DOI
Ernst, 1980, Circulation, 62, IV-41
Sacks, 1985, JAMA, 254, 1337, 10.1001/jama.1985.03360100087019 · DOI
Davis, 1980, Circulation, 62, IV-24
Enger, 1979, Artery, 5, 170
Levy, 1987, Circulation, 76, IV-167
Superko, 1986, JAMA, 256, 2714, 10.1001/jama.1986.03380190084030 · DOI
Hunninghake D, Gordon DJ, Tamir I, Rifkind BM. Management of hyperlipidemia. In: Pradhan SN, Maickel RP, Dutta SN, eds. Textbook of pharmacology. Bethesda, Md.: SP Press International, 1986:617–33.
Castelli, 1986, JAMA, 256, 2835, 10.1001/jama.1986.03380200073024 · DOI

Sorted by citations

Items 201–300 of 1,000

Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice
Yvan-Charvet, L., Ranalletta, M., Wang, N., Han, S., Terasaka, N., Li, R., Welch, C., & Tall, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33372 · Cited by 536
“Introduction Plasma HDL levels have a strong inverse relationship to the incidence of heart attack and stroke (1), but the underlying mechanisms are poorly understood.”
Anthocyanin Supplementation Improves HDL-Associated Paraoxonase 1 Activity and Enhances Cholesterol Efflux Capacity in Subjects With Hypercholesterolemia
Zhu, Y., Huang, X., Zhang, Y., Wang, Y., Liu, Y., Sun, R., & Xia, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2845 · Cited by 131
HDL Stimulation of Endothelial Nitric Oxide Synthase A Novel Mechanism of HDL Action
Mineo, C. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00098-7 · Cited by 127
Human Secretory Phospholipase A2Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice
Tietge, U. J. F., Maugeais, C., Lund‐Katz, S., Grass, D., deBeer, F. C., & Rader, D. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023228.90866.29 · Cited by 126
“These results indicate that (1) sPLA2 is of major importance for the decrease in plasma HDL levels in inflammatory states, and (2) SAA is not an activator of sPLA2 in vivo.”
Background
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader, D. J., Ikewaki, K., Duverger, N., Schmidt, H., Pritchard, H., Frohlich, J., Clerc, M., Dumon, M. F., Fairwell, T., & Zech, L. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116962 · Cited by 125
Elevated Soluble Cellular Adhesion Molecules in Subjects With Low HDL-Cholesterol
Calabresi, L., Gomaraschi, M., Villa, B., Omoboni, L., Dmitrieff, C., & Franceschini, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0402.105901 · Cited by 125
“Discussion The present data show that (1) individuals with low HDL-C levels have elevated plasma concentrations of sICAM-1 and sE-selectin, but individuals with high HDL-C levels have plasma sCAMs concentrations similar to healthy controls; (2) HDL-C is inversely and significantly associated with sICAM-1 and sE-select…”
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
Golforoush, P. A., Yellon, D. M., & Davidson, S. M. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-00829-5 · Cited by 135
“HDL cholesterol levels inversely correlate with the risk of atherosclerosis, most probably due to the role SRBI plays in reverse cholesterol transport [59, 94, 192].”
Background
Serum lipid levels in an Iranian adults population: Tehran lipid and glucose study
Azizi, F., Rahmani, M., Ghanbarian, A., Emami, H., Salehi, P., Mirmiran, P., & Sarbazi, N. (2003) · European Journal of Epidemiology · doi:10.1023/a:1023606524944 · Cited by 124
Fibrates Down-regulate Hepatic Scavenger Receptor Class B Type I Protein Expression in Mice
Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., Kozarsky, K., Altayó, M., Miquel, J. F., Luc, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211627200 · Cited by 124
High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease
Brewer, H. B. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000121505.88326.d2 · Cited by 126
Single Step Reconstitution of Multifunctional High-Density Lipoprotein-Derived Nanomaterials Using Microfluidics
Kim, Y., Fay, F., Cormode, D. P., Sánchez-Gaytán, B. L., Tang, J., Hennessy, E. J., Ma, M., Moore, K. J., Farokhzad, O. C., Fisher, E. A. A., et al. (2013) · ACS Nano · doi:10.1021/nn4039063 · Cited by 125
“basis for a high level of HDL and a decreased risk of coronary artery disease is suggested.(5)”
The Scavenger Receptor Class B Type I Adaptor Protein PDZK1 Maintains Endothelial Monolayer Integrity
Zhu, W., Saddar, S., Seetharam, D., Chambliss, K. L., Longoria, C., Silver, D. L., Yuhanna, I. S., Shaul, P. W., & Mineo, C. (2008) · Circulation Research · doi:10.1161/circresaha.107.159079 · Cited by 122
Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element
Uehara, Y., Miura, S.-I., von Eckardstein, A., Abe, S., Fujii, A., Matsuo, Y., Rust, S., Stefan Lorkowski, A., Assmann, G., Yamada, T., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.018 · Cited by 122
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
Hayek, T., Chajek‐Shaul, T., Walsh, A., Agellon, L. B., Moulin, P., Tall, A. R., & Breslow, J. L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115887 · Cited by 121
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease
Gotto, A. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.130301 · Cited by 118
Assembly of High-Density Lipoprotein
Yokoyama, S. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000195789.39418.e8 · Cited by 121
An Increased Coronary Risk Is Paradoxically Associated with Common Cholesteryl Ester Transfer Protein Gene Variations That Relate to Higher High-Density Lipoprotein Cholesterol: A Population-Based Study
Borggreve, S. E., Hillege, H. L., Wolffenbuttel, B. H. R., de Jong, P. E., Zuurman, M. W., van der Steege, G., van Tol, A., & Dullaart, R. P. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2322 · Cited by 121
Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study
Lupton, J. R., Faridi, K. F., Martin, S. S., Sharma, S., Kulkarni, K. R., Jones, S. R., & Michos, E. D. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.09.006 · Cited by 121
Coffee Consumption Enhances High-Density Lipoprotein-Mediated Cholesterol Efflux in Macrophages
Uto‐Kondo, H., Ayaori, M., Ogura, M., Nakaya, K., Ito, M., Suzuki, A., Takiguchi, S., Yakushiji, E., Terao, Y., Ozasa, H., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.206615 · Cited by 119
Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein
Shao, B., Oda, M. N., Oram, J. F., & Heinecke, J. W. (2006) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000231402.87232.aa · Cited by 119
High-density lipoproteins and atherosclerosis
Rader, D. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02635-8 · Cited by 116
Alternative forms of the scavenger receptor BI (SR-BI)
Webb, N. R., de Villiers, W. J. S., Connell, P. M., de Beer, F. C., & van der Westhuyzen, D. R. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37431-9 · Cited by 118
Reverse Cholesterol Transport—A Review of the Process and Its Clinical Implications
Hill, S., & McQueen, M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00098-2 · Cited by 117
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
Franceschini, G., Calabresi, L., Chiesa, G., Parolini, C., Sirtori, C. R., Canavesi, M., & Bernini, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1257 · Cited by 117
A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity.
Funke, H., von Eckardstein, A., Pritchard, P. H., Albers, J. J., Kastelein, J. J. P., Droste, C., & Assmann, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4855 · Cited by 115
Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease
Schaefer, J. R. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00053-2 · Cited by 114
“Low levels of HDL and apoA-I are independent risk factors for early development of CAD, whereas high levels are considered to be vasoprotective [7,39–43].”
Background
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides
Anantharamaiah, G. M., Mishra, V., Garber, D. W., Datta, G., Handattu, S. P., Palgunachari, M. N., Chaddha, M., Navab, M., Reddy, S. T., Segrest, J. P., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700010-jlr200 · Cited by 115
“Supplementary key words atherosclerosis & high density lipoprotein & hyperlipidemia & lipoproteins Epidemiological studies have established an inverse relationship between HDL and coronary artery disease (1).”
Background
Effects of dietary fatty acid composition on plasma cholesterol
Khosla, P., & Sundram, K. (1996) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00014-3 · Cited by 115
The Protective Role of Chinese Prescription Kangen-karyu Extract on Diet-Induced Hypercholesterolemia in Rats
Yokozawa, T., Cho, E. J., Sasaki, S., Satoh, A., Okamoto, T., & Sei, Y. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.760 · Cited by 115
HDL, lipid peroxidation, and atherosclerosis
Shao, B., & Heinecke, J. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.e900001-jlr200 · Cited by 115
The physiology of lipoproteins
Tulenko, T. N., & Sumner, A. E. (2002) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2002.128959 · Cited by 113
Acrolein Impairs ATP Binding Cassette Transporter A1-dependent Cholesterol Export from Cells through Site-specific Modification of Apolipoprotein A-I
Shao, B., Fu, X., McDonald, T. O., Green, P. S., Uchida, K., O’Brien, K. D., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508169200 · Cited by 114
Metabolic syndrome: the danger signal in atherosclerosis
Mathieu, P., Pîbarot, P., & Després, J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.285 · Cited by 117
High-density lipoprotein ameliorates palmitic acid-induced lipotoxicity and oxidative dysfunction in H9c2 cardiomyoblast cells via ROS suppression
Wu, K.-M., Hsu, Y., Ying, M.-C., Tsai, F., Tsai, C., Chung, J., Yang, J., Tang, C., Cheng, L.-Y., Su, P.-H., et al. (2019) · Nutrition & Metabolism · doi:10.1186/s12986-019-0356-5 · Cited by 113
Trends in Serum Lipid Levels during 1980-1992 in Children and Young Adults: The Cardiovascular Risk in Young Finns Study
Porkka, K. V. K., Raitakari, O. T., Leino, A., Laitinen, S., Räsänen, L., Rönnemaa, T., Marniemi, J., Lehtimäki, T. J., TAIMELA, S. P., Dahl, M. R., et al. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009192 · Cited by 113
“has gained increasing attention during recent years ( 11-14 ).”
Background
Effects of Fasting During Ramadan Month on Cognitive Function in Muslim Athletes
Tian, H.-H., Aziz, A. R., Png, W., Wahid, M. F., Yeo, D. H. H., & Png, A.-L. C. (2011) · Asian Journal of Sports Medicine · doi:10.5812/asjsm.34753 · Cited by 114
Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1
Lambert, G. C., Chase, M. B., Dugi, K. A., Bensadoun, A., Brewer, H. B., & Santamarina-Fojo, S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33491-x · Cited by 113
Lipoproteomics: using mass spectrometry-based proteomics to explore the assembly, structure, and function of lipoproteins
Hoofnagle, A. N., & Heinecke, J. W. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900015-jlr200 · Cited by 117
Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma.
Huang, Y., von Eckardstein, A., & Assmann, G. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.3.445 · Cited by 112
HDL is the major lipoprotein carrier of plasma F2-isoprostanes
Proudfoot, J. M., Barden, A. E., Loke, W. M., Croft, K. D., Puddey, I. B., & Mori, T. A. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800607-jlr200 · Cited by 111
“protection from the development of these diseases (1, 2).”
Background
Effect of dietary bile acids on growth, body composition, lipid metabolism and microbiota in grass carp (Ctenopharyngodon idella)
Zhou, J., Chen, H. J., Ji, H., Shi, X., Li, X. X., Chen, L., Du, Z., & Yu, H. (2017) · Aquaculture Nutrition · doi:10.1111/anu.12609 · Cited by 111
“Apolipoprotein A- I (apoA- I) is the major protein component of HDL, and it is generally considered to protect against the development of atherosclerosis induced by cholesterol in mammals (Gordon & Rifkind, 1989; Rubin, Krauss, Spangler, Verstuyft, & Clift, 1991).”
Background
Sterol Regulatory Element-Binding Protein-1a Binds to cis Elements in the Promoter of the Rat High Density Lipoprotein Receptor SR-BI Gene
Lopez, D., & McLean, M. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7220 · Cited by 114
The Impact of Postprandial Lipemia in Accelerating Atherothrombosis
Roche, H. M., & Gibney, M. J. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700504 · Cited by 110
Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
Moradi, H., Streja, E., Kashyap, M. L., Vaziri, N. D., Fonarow, G. C., & Kalantar‐Zadeh, K. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu022 · Cited by 111
“Therefore, it is not surprising that in the general population, increasing HDL cholesterol concentrations are associated with decreased atherosclerosis burden and reduced CV mortality [21–24].”
BackgroundResult
Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI
Valiyaveettil, M., Kar, N. S., Ashraf, M. Z., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2007) · Blood · doi:10.1182/blood-2007-08-107813 · Cited by 108
“Introduction The protective role of high-density lipoprotein (HDL) in coronary heart disease is well established and attributed to the ability of HDL to promote reverse cholesterol transport as well as its anti-oxidant, anti-inflammatory, and anti-thrombotic activities.(1-6) One potential mechanism for the anti-thromb…”
Background
Reduction of Blood Pressure, Plasma Cholesterol, and Atherosclerosis by Elevated Endothelial Nitric Oxide
van Haperen, R., de Waard, M., van Deel, E. D., Mees, B., Kutryk, M., van Aken, T., Hamming, J. F., Grosveld, F. G., Duncker, D. J., & de Crom, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209477200 · Cited by 108
ATP-Binding Cassette Transporter G1 and High-Density Lipoprotein Promote Endothelial NO Synthesis Through a Decrease in the Interaction of Caveolin-1 and Endothelial NO Synthase
Terasaka, N., Westerterp, M., Koetsveld, J., Fernández-Hernando, C., Yvan-Charvet, L., Wang, N., Sessa, W. C., & Tall, A. R. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.213215 · Cited by 107
Phosphatidylinositol increases HDL-C levels in humans
Burgess, J. W., Neville, T. A.-M., Rouillard, P., Harder, Z., Beanlands, D. S., & Sparks, D. L. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400438-jlr200 · Cited by 107
“It is becoming increasingly evident that low HDL-C can be an independent risk predictor of CAD even when LDL-C is low (17).”
Influential
Apolipoprotein-mediated cellular cholesterol efflux
Yokoyama, S. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(98)00032-0 · Cited by 107
Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.
Wu, F. C. W., Farley, T. M. M., Peregoudov, A., & Waites, G. M. H. (1996) · PubMed · Cited by 107
Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive
Oka, T., Kujiraoka, T., Ito, M., Egashira, T., Takahashi, S., Nanjee, M. N., Miller, N. E., Metso, J., Olkkonen, V. M., Ehnholm, C., et al. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31998-2 · Cited by 106
“Even though an inverse correlation between CHD risk and serum HDL levels has been well documented (1), the mechanism(s) underlying the antiatherogenecity of HDL are not clear.”
Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein
Syvänne, M., Castro, G., Dengremont, C., Geitere, C. D., Jauhiainen, M., Ehnholm, C., Michelagnoli, S., Franceschini, G., Kahri, J., & Taskinen, M. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05962-x · Cited by 105
“I/ Atherosclerosis 127 (1996) 245-253 247”
Influential
Cardiolipin is a normal component of human plasma lipoproteins
Deguchi, H., Fernández, J. A., Hackeng, T. M., Banka, C. L., & Griffin, J. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1743 · Cited by 105
Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
Francone, O. L., Royer, L. J., & Haghpassand, M. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39156-2 · Cited by 104
Antiatherogenic Functionality of High Density Lipoprotein: How Much versus How Gooden-subtitle=
Sviridov, D., Mukhamedova, N., Remaley, A. T., Chin-Dusting, J. P. F., & Nestel, P. J. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e571 · Cited by 105
Estrogen Activates the High-Density Lipoprotein Receptor Gene via Binding to Estrogen Response Elements and Interaction with Sterol Regulatory Element Binding Protein-1A
Lopez, D., Sanchez, M. D., Shea-Eaton, W. K., & McLean, M. P. (2002) · Endocrinology · doi:10.1210/endo.143.6.8855 · Cited by 104
The effects of Coptidis Rhizoma extract on a hypercholesterolemic animal model
Yokozawa, T., Ishida, A., Cho, E. J., & Nakagawa, T. (2003) · Phytomedicine · doi:10.1078/094471103321648610 · Cited by 104
Caveolins and macrophage lipid metabolism
Gargalovic, P. S., & Dory, L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200005-jlr200 · Cited by 104
Friend Turns Foe: Transformation of Anti-Inflammatory HDL to Proinflammatory HDL during Acute-Phase Response
Hima Bindu, G., Rao, V., & Kakkar, V. V. (2010) · Cholesterol · doi:10.1155/2011/274629 · Cited by 104
Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
Schultz, J. R., Gong, E. L., McCall, M. R., Nichols, A. V., Clift, S., & Rubin, E. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36658-x · Cited by 104
Cardiometabolic Risk in Community-Dwelling Persons With Chronic Spinal Cord Injury
Groah, S. L., Nash, M. S., Ward, E., Libin, A., Mendez, A. J., Burns, P. A., Elrod, M., & Hamm, L. F. (2011) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e3181f68aba · Cited by 103
Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease
Calabresi, L., Simonelli, S., Gomaraschi, M., & Franceschini, G. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.034 · Cited by 103
“Several prospective studies performed in the 1970s and 1980s howed a strong inverse correlation between the plasma concenration of high density lipoprotein cholesterol (HDL-C) and incident oronary heart disease (CHD) [1].”
Background
Influence of Amla (Emblica officinalis Gaertn.) on Hypercholesterolemia and Lipid Peroxidation in Cholesterol-Fed Rats
Kim, H. J., Yokozawa, T., Kim, H. Y., Tohda, C., Theertham Pradyumna, R. A. O., & Juneja, L. R. (2005) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.51.413 · Cited by 102
High Density Lipoprotein–Induced Angiogenesis Requires the Activation of Ras/MAP Kinase in Human Coronary Artery Endothelial Cells
Miura, S.-I., Fujino, M., Matsuo, Y., Kawamura, A., Tanigawa, H., Nishikawa, H., & Saku, K. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000066134.79956.58 · Cited by 102
In-Depth Haplotype Analysis of ABCA1 Gene Polymorphisms in Relation to Plasma ApoA1 Levels and Myocardial Infarction
Trégouët, D., Ricard, S., Nicaud, V., Reguigne-Arnould, I., Soubigou, S., Rosier, M., Duverger, N., Poirier, O., Macé, S., Kee, F., et al. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000121573.29550.1a · Cited by 102
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states
Rashid, S., Uffelman, K. D., & Lewis, G. F. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00191-x · Cited by 101
Apolipoprotein A-IMilano: current perspectives
Chiesa, G., & Sirtori, C. R. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00007 · Cited by 101
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?
von Eckardstein, A., & Assmann, G. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00010 · Cited by 98
A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: Is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?
Zoratti, R. (1998) · European Journal of Epidemiology · doi:10.1023/a:1007492202045 · Cited by 98
“Low HDL-C is a well known independent predictor of CHD [74], and high HDL-C appears to be effective in preventing CHD in both white [75] and black people [76, 77].”
Background
Rationale and design of the Department of Veterans Affairs high-density lipoprotein cholesterol Intervention Trial (HIT) for secondary prevention of coronary artery disease in men with low high-density lipoprotein cholesterol and desirable low-density lipoprotein cholesterol
Bloomfield, H. E., Robins, S. J., Iwane, M. K., Boden, W. E., Elam, M. B., Fye, C. L., Gordon, D. J., Schaefer, E. J., Schectman, G., & Wittes, J. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90708-k · Cited by 99
Self-citation
Effect of Alcohol on Lipids and Lipoproteins in Relation to Atherosclerosis
Hannuksela, M. L., Liisanantti, M. K., & Savolainen, M. J. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795529 · Cited by 97
Comparison of Ethinyl-Estradiol Plus Cyproterone AcetateVersusMetformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome
Luque‐Ramírez, M., Álvarez‐Blasco, F., Botella-Carretero, J. I., Martínez‐Bermejo, E., Lasunción, M. A., & Escobar-Morreale, H. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0282 · Cited by 96
Apolipoprotein AI and Transthyretin as Components of Amyloid Fibrils in a Kindred with apoAI Leu178His Amyloidosis
Sousa, M. M., Vital, C., Ostler, D., Fernandes, R., Pouget-Abadie, J., Carles, D., & Saraiva, M. J. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65064-x · Cited by 97
Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring; their comparison with matched controls and response to treatment
Davies, R. J., TURNER, R., Crosby, J., & Stradling, J. R. (1994) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1994.tb00126.x · Cited by 98
Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?
Parodi, P. W. (2009) · International Dairy Journal · doi:10.1016/j.idairyj.2009.01.001 · Cited by 99
Recombinant Apolipoprotein A-I Milano Dimer Inhibits Carotid Intimal Thickening Induced by Perivascular Manipulation in Rabbits
Soma, M. R., Donetti, E., Parolini, C., Sirtori, C. R., Fumagalli, R., & Franceschini, G. (1995) · Circulation Research · doi:10.1161/01.res.76.3.405 · Cited by 97
Modified HDL: Biological and physiopathological consequences
Norata, G. D., Pirillo, A., & Catapano, A. L. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.01.012 · Cited by 96
The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease
Brewer, H. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0163 · Cited by 96
Signaling by the High-Affinity HDL Receptor Scavenger Receptor B Type I
Saddar, S., Mineo, C., & Shaul, P. W. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.196170 · Cited by 95
“1): (1) its capacity to invoke cholesterol flux, (2) its”
Transthyretin in high density lipoproteins: association with apolipoprotein A-I
Sousa, M. M., Berglund, L., & Saraiva, M. J. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32074-5 · Cited by 94
Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors
Kauma, H., Savolainen, M. J., Heikkilä, R., Rantala, A. O., Lilja, M., Reunanen, A., & Kesäniemi, Y. A. (1996) · Human Genetics · doi:10.1007/bf02265258 · Cited by 95
“Many epidemiologicat studies have shown that there is an inverse relationship between the plasma high density lipoprotein (HDL) cholesterol level and the risk of premature atherosclerotic coronary heart disease (Gordon and Rifkind 1989).”
Background
Physical Activity and Lipoprotein Lipid Disorders
Berg, A., Frey, I., Baumstark, M. W., Halle, M., & Keul, J. (1994) · Sports Medicine · doi:10.2165/00007256-199417010-00002 · Cited by 96
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis.
Rader, D. J., Gregg, R., Meng, M., Schaefer, J., Zech, L. A., Benson, M. D., & Brewer, H. B. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41439-7 · Cited by 94
Adenovirus mediated overexpression of human phospholipid transfer protein alters plasma HDL levels in mice
Ehnholm, S., van Dijk, K. W., Hof, B. V. ’., van der Zee, A., Olkkonen, V. M., Jauhiainen, M., Hofker, M. H., Havekes, L. M., & Ehnholm, C. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32549-9 · Cited by 94
Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension
Horio, T. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01015-x · Cited by 95
“A positive association between total and low-density lipoprotein (LDL) cholesterol and coronary heart disease is well established, and low high-density lipoprotein (HDL) cholesterol and elevated triglycerides are also known to be risk factors for coronary events.(16,17) Despite the growing evidence concerning the impa…”
Background
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia
Real, J. T. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2408 · Cited by 93
Moderate Wine and Alcohol Consumption: Beneficial Effects on Cardiovascular Disease
Parks, D. A., & Booyse, F. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616080 · Cited by 92
High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program
Curb, J. D., Abbott, R. D., Rodríguez, B. L., Masaki, K., Chen, R., Popper, J. S., Petrovitch, H., Ross, G. W., Schatz, I. J., Belleau, G. C., et al. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh177 · Cited by 93
Quantification of HDL Particle Concentration by Calibrated Ion Mobility Analysis
Hutchins, P. M., Ronsein, G. E., Monette, J. S., Pamir, N., Wimberger, J., He, Y., Anantharamaiah, G. M., Kim, D. S., Ranchalis, J., Jarvik, G. P., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.228114 · Cited by 92
“Particle concentrations determined in triplicate by IMA [26 (1) nmol/L] and by total protein (30.”
Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study**Supported by the United Nations Development Programme/United Nations Fund for Population/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, and by the U.S. Agency for International Development through the Contraceptive Research and Development (CONRAD) program, contract CSA-88-024 to the United States center, University of Washington, Seattle, Washington.
Wu, F. C. W., Farley, T. M. M., Peregoudov, A., & Waites, G. M. H. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58166-7 · Cited by 120
Association between rheology and components of lipoproteins in human blood. Results from the MONICA project.
Köenig, W., Sund, M., Ernst, E., Wilfried, M. R. A. Z., Hombach, V., & Keil, U. (1992) · Circulation · doi:10.1161/01.cir.85.6.2197 · Cited by 92
Regulation of signal transduction by HDL
Mineo, C., & Shaul, P. W. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r039479 · Cited by 96
Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL
Hutchins, P. M., & Heinecke, J. W. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000209 · Cited by 97
“In contrast, HDL-cholesterol (HDL-C) has a strong inverse association with CVD [1].”
Background
HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes
Meurs, I., Hoekstra, M., van Wanrooij, E. J. A., Hildebrand, R. B., Kuiper, J., Kuipers, F., Hardeman, M. R., van Berkel, T. J. C., & Eck, M. V. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.004 · Cited by 91
Tamoxifen Decreases Cholesterol Sevenfold and Abolishes Lipid Lesion Development in Apolipoprotein E Knockout Mice
Reckless, J., Metcalfe, J. C., & Grainger, D. J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1542 · Cited by 91
HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity.
Epand, R. M., Stafford, A. R., Leon, B., Lock, P., Tytler, E. M., Segrest, J. P., & Anantharamaiah, G. M. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1775 · Cited by 91
Using Advanced Intercross Lines for High-Resolution Mapping of HDL Cholesterol Quantitative Trait LociPreprint
Wang, X., Roy, I. L., Nicodeme, E., Li, R. H., Wagner, R., Petros, C., Churchill, G. A., Harris, S., Darvasi, A., Kirilovsky, J., et al. (2003) · Genome Research · doi:10.1101/gr.1185803 · Cited by 91
“Haley and Knott (1992) analyzed a simulated regression in which a presumed single QTLmay localize in the middle of what are actually two linked QTLs.”
Background
Proteasomal Inhibition Promotes ATP-Binding Cassette Transporter A1 (ABCA1) and ABCG1 Expression and Cholesterol Efflux From Macrophages In Vitro and In Vivo
Ogura, M., Ayaori, M., Terao, Y., Hisada, T., Iizuka, M., Takiguchi, S., Uto‐Kondo, H., Yakushiji, E., Nakaya, K., Sasaki, M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228478 · Cited by 94
Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In Vivo
Asleh, R., Miller‐Lotan, R., Aviram, M., Hayek, T., Yulish, M., Levy, J. E., Miller, B. T., Blum, S., Milman, U., Shapira, C., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000251741.65179.56 · Cited by 90
Gene-environment interaction: a central concept in multifactorial diseases
Tiret, L. (2002) · Proceedings of The Nutrition Society · doi:10.1079/pns2002178 · Cited by 90

Authors: Desforges, J. F., Gordon, D. J., & Rifkind, B. M.
Affiliations: National Heart, Lung, and Blood Institute (US)
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1989-11-09
Volume: 321
Issue: 19
Pages: 1311-1316
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198911093211907
OpenAlex: W2339616051
Cited by: 1,547
References: 50
Citations by year: 2026: 9 · 2025: 6 · 2024: 15 · 2023: 19 · 2022: 13 · 2021: 22 · 2020: 22 · 2019: 30 · 2018: 21 · 2017: 24 · 2016: 36 · 2015: 47 · 2014: 42 · 2013: 42 · 2012: 38
FWCI: 9.17
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, HDL cholesterol, coronary artery disease, atherogenesis, cardioprotection, HDL metabolism, Helsinki Heart Study
MeSH terms: Coronary Disease, Humans, Lipoproteins, HDL, Cholesterol, HDL

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

High-Density Lipoprotein — The Clinical Implications of Recent Studies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks